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The isolation of the CHCl3 soluble extract of Kaempferia pulchra rhizomes afforded seven 
new isopimarane diterpenoids, kaempulchraols I−O, together with one known analogue. The 
structures of these compounds were elucidated using 1D and 2D NMR and X-ray diffraction 
analyses. The antiproliferative activity of the isolated compounds was evaluated against a 
panel of five human cancer cell lines. Kaempulchraol L exhibited weak antiproliferative 
activity against PANC-1 and PSN-1 cells with IC50 values of 39.9 and 22.6 µM, respectively. 
 



















Natural products have played important roles as drug resources for humans since time 
immemorial. Most people in the developing countries rely on traditional medicine for 
their primary health care. In particular, the people of Myanmar have used traditional 
formulations which are mainly composed of medicinal plants. Natural products derived 
from plants have contributed significantly to the development of anticancer drugs. For 
instance, vinblastine, vincristine, podophyllotoxin, etoposide, indirubins, flavopiridol, 
rohitukine, paclitaxel and irinotecan are the anticancer agents derived from plants used in 
traditional medicines.1,2 In our ongoing research for the discovery of anticancer agents 
from Myanmar medicinal plants,3−7 we screened the crude extracts and found that the 
CHCl3 soluble fraction of rhizomes from Kaempferia pulchra Ridl. (Zingiberaceae) 
exhibited reasonable antiproliferative activity against a panel of five human cancer cell 
lines including A549 (human lung cancer), HeLa (human cervix cancer), PANC-1 and 
PSN-1 (human pancreatic cancer), and MDA-MB-231 (human breast cancer), and TIG-3 
(normal human primary fibroblast cells). A series of chromatographic separations 
furnished eight new isopimarane diterpenoids, kaempulchraols A−H, together with five 
known ones [9α-hydroxyisopimara-8(14),15-dien-7-one,8 7β,9α-dihydroxypimara- 
8(14),15-diene,9 (1S,5S,9S,10S,11R,13R)-1,11-dihydroxypimara-8(14),15-diene,10 
sandaracopimaradien-1α,2α-diol,11 and (2R)-ent-2-hydroxyisopimara-8(14),15-diene]12 in 
our previous study.7 As a continuation of that work, the isolation of the remaining 
fractions obtained from the CHCl3 extract of K. pulchra afforded seven new diterpenoids, 
kaempulchraols  I−O (1−7) together with one known compound (Fig. 1), 
(1R,2S,5S,9S,10S,11R,13R)-1,2,11-trihydroxypimara-8(14),15-diene (8).10 Herein, we 
report the structure elucidation of the new compounds and the antiproliferative activity of 
the isolated diterpenoids. 
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Figure 1. Structures of compounds 1−8 isolated from K. pulchra rhizomes. 
 
2. Results and discussion 
2.1. Structure elucidation of new compounds 
Compound 1 was obtained as an amorphous solid, and its molecular formula was 
determined as C20H32O from the HREIMS and 13C NMR data. The IR spectrum of 1 showed 
absorption bands due to hydroxy and olefinic groups at 3386 and 1635 cm−1, respectively. 
The 1H NMR spectrum (Table 1) displayed signals due to terminal vinyl protons [δH 5.79, dd, 
(J = 17.4, 10.7 Hz, H-15), 4.93, dd (J = 17.4, 1.4 Hz, H-16a), 4.90, dd (J = 10.7, 1.4 Hz, 
H-16b)], four methines including olefinic and oxygenated ones [δH 5.27, br s (H-14), 3.72, br 
s (H-1β), 2.28, t (J = 7.2 Hz, H-9α), 1.43, m (H-5α)], six methylene signals, and four tertiary 
methyls [δH 1.06 (H3-17), 0.88 (H3-18), 0.93 (H3-19), 0.80 (H3-20)]. The 13C NMR spectrum 
(Table 2) revealed 20 signals including four olefins (δC 149.0, 137.4, 129.0, 110.1), one 
oxygenated methine (δC 71.9), two methines (δC 47.7, 43.4), three quaternary carbons (δC 
41.8, 37.3, 33.0), six methylenes (δC 35.6, 34.4, 34.0, 25.8, 22.5, 18.1) and four methyls (δC 
33.5, 26.0, 22.3, 15.4). These data were similar to those of kaempulchraol E,7 except for the 
absence of one of the oxygenated methines of kaempulchraol E, suggesting that 1 was a 
Δ8(14),15 monohydroxyisopimaradiene. The hydroxy group was determined to be at C-1, due to 
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the 1H−13C HMBC correlations of H-1β (δH 3.72, br s) to C-3 (δC 34.0) and C-5 (δC 47.7), 
and of H-3α (δH 1.71, m), H-3β (δH 1.19, m), and H3-20 (δH 0.80, s) to C-1 (δC 71.9) (Fig. 2). 
The NOESY correlations (Fig. 3) between H-1β and H-2β (δH 1.87, m)/H-11β (δH 1.54, 
m)/H3-20 suggested that the C-1 hydroxy group adopts the α orientation. Furthermore, the 
NOESY correlations between H-11β (δH 1.54, m) and H3-17 (δH 1.06, s)/H3-20 (δH 0.80, s), 
and between H3-18 (δH 0.88, s) and H3-20 suggested that they all exist in the axial positions. 
Interestingly, the spectroscopic data of 1 were very similar to those of the reported marginatol 
(6α-hydroxyisopimara-8(14),15-diene).13 However, careful analyses of the 1D and 2D NMR 
data as mentioned above, revealed that the structure of 1 is not a 6α-hydroxy derivative. Thus, 
the structure of 1 was assigned as 1α-hydroxyisopimara-8(14),15-diene, and the compound 
was named kaempulchraol I. 
 
Figure 2. COSY (bold lines) and key HMBC (1H → 13C) (arrows) correlations in compounds 1−7. 
 
Figure 3. Key NOESY correlations (white arrows) in compounds 1 and 4. 
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Table 1  
1H NMR spectroscopic data (600 MHz, CDCl3) for kaempulchraols I−M (1−5), (δ in ppm and J 
values in (Hz) in parentheses) 
Position 1  2 3 4  5 
1α   1.74, td  
(12.9, 3.9) 
1.83, m  
1β 3.72, br s 3.79, br t (2.5) 1.42, m 1.31, m 3.99, br d (1.5) 
2α 1.59, m 1.62, m 1.52a, m 1.46, m  
2β 1.87, m 1.96, tdd  
(14.5, 3.5, 2.2) 
1.61, m 1.58, m 3.86, m 
3α 1.71, m 1.75, td  
(14.0, 3.5) 
1.26, m 1.22, m 1.79, t (12.3) 
3β 1.19, m 1.27, dt 
(14.0, 3.5) 
1.37, m 1.32, m 1.41, ddd 
(12.3, 4.2, 0.8) 
5α 1.43, m 1.91, dd  
(13.7, 5.2) 
2.01, d (2.2) 1.90, d (2.0) 2.20, dd  
(12.7, 3.1) 
6α 1.61, m 2.58, dd 
(18.5, 5.2) 
5.37, quin (2.3) 4.30, br s 1.61, m 
6β 1.34, m 2.31, dd  
(18.5, 13.7) 
  1.35, qdd  
(17.7, 12.7, 4.8) 
7α 2.25, m  2.67, dddd 
(15.4, 6.4, 4.0, 2.3) 
2.46, dddd 
(13.9, 5.9, 3.8, 2.1) 
2.09, ddd 
(14.4, 5.7, 2.4) 
7β 2.04, m  2.20, dd  
(15.4, 2.4) 
2.04, dd  
(13.9, 2.8) 
2.48, tdd  
(14.1, 5.9, 2.4) 
9α 2.28, t (7.2) 2.69, m    
11α 1.69, m 1.87, m 1.56, m 1.66, m 1.84, dt  
(14.1, 3.7) 
11β 1.54, m 1.47, m 2.12, m 1.85, m 2.03, ddd  
(17.7, 14.1, 3.7) 
12α 1.42, m 1.57, m 1.57, m 1.58, m 1.73, td  
(13.5, 3.5) 
12β 1.49, m 1.64, m 1.52a, m 1.64, m 1.48, dt  
(13.2, 3.7) 
14 5.27, br s  6.73, br t  
(1.6) 
5.35, br t (1.7) 5.72, br d (1.8) 5.32, br t (1.7) 
15 5.79, dd 
(17.4, 10.7) 




5.83, dd  
(17.5, 10.5) 
5.82, dd  
(17.5, 10.6) 
16-a 4.93, dd  
(17.4, 1.4) 
5.02, dd  
(17.5, 0.9) 
4.99, dd  
(17.5, 1.2) 
4.99, dd  
(17.5, 1.3) 
4.99, dd  
(17.5, 1.2) 
16-b 4.90, dd  
(10.7, 1.4) 
4.99, dd  
(10.5, 0.9) 
4.96, dd  
(10.6, 1.2) 
4.96, dd  
(10.5, 1.3) 
4.94, dd  
(10.6, 1.2) 
17 1.06, s 1.11, s 1.07, s 1.08, s 1.04, s 
18 0.88, s 0.93, s 1.02, s 1.24, s 0.94, s 
19 0.93, s 0.91, s 1.00, s 1.01, s 1.01, s 
20 0.80, s 0.85, s 1.21, s 1.25, s 0.89, s 
OH-1     4.13, br s 
O-CO-Me-6   2.02, s   
OH-9   3.47, s  3.59, s 
OMe-9    3.10, s  
OMe-14      






13C NMR spectroscopic data (150 MHz, CDCl3) for kaempulchraols I−O (1−7), (δ in ppm) 
Position 1  2 3 4  5  6 7 
1 71.9 71.1 33.8 33.7 76.7 72.9 73.1 
2 25.8 25.9b 18.7 18.9 67.0 25.1 24.4 
3 34.0 33.8 43.6 43.6 42.3 35.7 35.7 
4 33.0 32.9 33.9 34.2 33.9 33.6 33.6 
5 47.7 43.3 46.6 48.0 38.9 46.3 46.3 
6 22.5 37.1 70.2 68.8 21.8 65.8 65.7 
7 35.6 200.4 37.6 42.5 31.2 40.5 40.5 
8 137.4 135.6 134.0 132.2 136.2 127.8 127.8 
9 43.4 43.7 74.6 79.4 77.2 136.9 137.4 
10 41.8 39.7 42.5 44.4 44.4 42.6 42.6 
11 18.1 18.4 27.0 22.1a 27.0 19.8 20.6 
12 34.4 33.9 31.9 34.6 31.1 29.6 29.0 
13 37.3 38.5 37.9 37.4 37.6 40.1 40.7 
14 129.0 144.3 133.8 137.8 131.8 77.3 84.3 
15 149.0 146.3 147.9 147.5 148.3 143.2 144.8 
16 110.1 111.7 110.7 111.1 110.5 114.6 111.7 
17 26.0 25.8b 24.2 26.8 23.6 22.8 24.1 
18 22.3 21.3 23.8 22.1a 23.5 23.8 23.5 
19 33.5 32.4 33.7 33.9 33.7 33.5 33.5 
20 15.4 14.2 21.2 24.4 17.9 21.6 21.3 
O-CO-Me-6   21.8     
O-CO-Me-6   170.5     
OMe-9    50.8    
OMe-14       62.0 
aOverlapping resonances within the same column. bThese assignments may be reversed. δ values were measured 
from the HMQC spectrum. 
 
Compound 2 was obtained as an amorphous solid, and its molecular formula was 
determined as C20H30O2 by the HREIMS and 13C NMR data. The absorption bands at 3453, 
1681, and 1634 cm−1 in the IR spectrum indicated the presence of hydroxy, conjugated 
carbonyl, and olefinic groups in 2. The 1H and 13C NMR spectroscopic data (Tables 1 and 2) 
of 2 were similar to those of 1, except for the presence of a carbonyl carbon (δC 200.4) and 
the downfield shift of H-14 (δH 6.73) in 2. Thus, 2 was considered to be a derivative of 1 with 
an additional carbonyl group, which may be in the proximity of C-14. The HMBC 
correlations (Fig. 2) of H-1β (δH 3.79) to C-3/C-5/C-9, and those of H-5α (δH 1.91), H2-6 (δH 
2.31, 2.58), H-9α (δH 2.69), and H-14 (δH 6.73) to the carbonyl carbon (δC 200.4) suggested 
the attachment of these hydroxy and carbonyl groups to C-1 and C-7, respectively. The 
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relative orientation of the C-1 hydroxy group was deduced as the α configuration since an 
oxygenated methine (δH 3.79, H-1β) provided NOESY correlations with H3-20 (δH 0.85, s) 
and H-11β (δH 1.47). Accordingly, the structure of 2 was deduced as 
1α-hydroxy-7-oxoisopimara-8(14),15-diene, and the compound was named kaempulchraol J.       
Compound 3 was obtained as an amorphous solid and its molecular formula, C22H34O3, 
was determined via the HREIMS and 13C NMR data. The 1H and 13C NMR spectroscopic 
data (Tables 1 and 2) suggested that 3 was a Δ8(14),15 monohydroxyisopimaradiene with an 
acetoxy group [δH 2.02, s (-O-CO-Me), δC 21.8 (-O-CO-Me), 170.5 (-O-CO-Me)]. The 
downfield shift of an oxygenated methine (δH 5.37, quin, J = 2.3 Hz) suggested that it was an 
acetoxy group bearing proton. These data were similar to those of the reported 
6β-acetoxysandaracopimaradiene-9α-ol-1-one,14 an isolate from the same plant native to 
Thailand, except for the lack of a carbonyl group in 3. The HMBC correlations of H-6α (δH 
5.37, quin, J = 2.3 Hz) to C-5/C-8 and of H2-11 (δH 1.56, 2.12, both m), H-14 (δH 5.35, br t, J 
= 1.7 Hz), and H3-20 (δH 1.21, s) to C-9 (δC 74.6) revealed the location of the acetoxy group 
at C-6 and the presence of a hydroxy group at C-9, respectively (Fig. 2). The NOESY 
correlations of H-6α and H-5α/H-7α confirmed the relative configuration of the C-6 acetoxy 
as β orientation. However, C-9 hydroxy group was assumed as α orientation based on the 
biogenetic point of view. Hence, 3 was established as 
6β-acetoxy-9α-hydroxyisopimara-8(14),15-diene, and was named kaempulchraol K. 
Compound 4 was isolated as a colorless oil. Its molecular formula was determined to be 
C21H34O2 from the HREIMS and 13C NMR data. Its 1H and 13C NMR spectroscopic data 
along with the COSY and HMQC data (Tables 1 and 2, Fig. 2) indicated that 4 was a Δ8(14),15 
monohydroxyisopimaradiene with a methoxy group (δH 3.10, s; δC 50.8). The unusual high 
field 13C NMR chemical shift of this methoxy group suggested that it may be attached to the 
quaternary carbon. The HMBC correlations (Fig. 2) of an oxygenated methine (δH 4.30, br s) 
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to C-5/C-7/C-8/C-10, of H-5α/H2-7/H-14 to C-9, and of methoxy protons (δH 3.10, s) to C-9 
(δC 79.4) allowed us to confirm the presence of these hydroxy and methoxy groups at C-6 
and C-9, respectively. The NOESY correlations described in Figure 3 confirmed that 4 was 
6β-hydroxy-9α-methoxyisopimara-8(14),15-diene, and the compound was named 
kaempulchraol L. Interestingly, this is the first report of the presence of a methoxy group at 
C-9 of a Δ8(14),15 isopimarane diterpene skeleton.  
Compound 5 was obtained as colorless needles from acetone. The molecular formula of 5 
was determined to be C20H32O3, from the quasi-molecular ion peak at m/z 343 in the FAB 
(fast atom bombardment) mass spectrum, and this was further supported by HRFABMS (m/z 
343.2233, calcd 343.2249, [C20H32O3Na]+). The 1H NMR spectrum (Table 1) of 5 displayed 
signals for a Δ8(14),15 isopimaradiene skeleton including terminal vinyl protons [δH 5.82, dd (J 
= 17.5, 10.6 Hz, H-15), 4.99, dd (J = 17.5, 1.2 Hz, H-16a), 4.94, dd (J = 10.6, 1.2 Hz, 
H-16b)], an olefinic methine [δH 5.32, br t (J = 1.7 Hz, H-14)], two oxygenated methines [δH 
3.86, m (H-2β), 3.99 br d (J = 1.5 Hz, H-1β)], two hydroxy protons [δH 4.13, br s (OH-1α), 
3.59, s (OH-9α)], five methylenes and four methyl singlets [δH 1.04 (H3-17), 0.94 (H3-18), 
1.01 (H3-19), 0.89 (H3-20)]. The detailed analysis of the HMQC and 13C NMR spectroscopic 
data (Table 2) of 5 revealed the presence of four olefins, three methines including two 
oxygenated ones, four quaternary carbons including an oxygenated one, five methylenes and 
four methyl groups. These data revealed that 5 was a Δ8(14),15 trihydroxyisopimaradiene. The 
COSY correlations between the two oxygenated methines and the HMBC correlations (Fig. 
2) of H-1β (δH 3.99, br d, J = 1.5 Hz) to C-2/C-3/C-5/C-9/C-20, of H-2β (δH 3.86, m) to 
C-1/C-3/C-4/C-10, and of OH-9α (δH 3.59, s) to C-8/C-9/C-10 confirmed the attachment of 
these hydroxyl groups at C-1, C-2, and C-9, respectively. The 2D NOESY correlations of 
H-1β and H-2β to H3-20 and of OH-9α to H-5α/H-11α/H-12α (Fig. 4a), and the X-ray 
diffraction analysis (Fig. 4b) revealed the orientations of the C-1, C-2, and C-9 hydroxy 
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groups as the α configurations. Consequently, its structure was established as 
1α,2α,9α-trihydroxyisopimara-8(14),15-diene and was named kaempulchraol M.  
 
Figure 4. Key NOESY correlations (dashed arrows) (a) and ORTEP drawing (b) of compound 5. 
Compound 6 was isolated as colorless needles. The HREIMS analysis of 6 afforded a 
molecular ion at m/z 320.2342 consistent with the molecular formula of C20H32O3. The 1H 
NMR spectrum of 6 displayed protons of a terminal vinyl [δH 6.00, dd (J = 17.7, 10.9 Hz, 
H-15), 5.14, dd (J = 17.7, 1.5 Hz, H-16a), 5.18, dd (J = 10.9, 1.5 Hz, H-16b)], four methines 
including three oxygenated ones [δH 3.80, t (J = 2.8 Hz, H-1β), 1.63, br s (H-5α), 4.58, d (J = 
4.8 Hz, H-6α), 3.56, br s (H-14)], five methylenes and four singlets of methyls [δH 1.04 
(H3-17), 1.23 (H3-18), 1.03 (H3-19), 1.37 (H3-20)]. The 13C NMR spectrum showed four 
olefinic carbons (δC 143.2, 136.9, 127.8, 114.6), four methines including three oxygenated 
ones (δC 77.3, 72.9, 65.8, 46.3), five methylenes (δC 40.5, 35.7, 29.6, 25.1, 19.8), three 
quaternary carbons (δC  42.6, 40.1, 33.6), and four methyls (δC 33.5, 23.8, 22.8, 21.6). The 
absence of an olefinic methine proton of C-14 and the presence of four olefinic carbons and 
three oxygenated methines suggested that 6 was a trihydroxy analogue of a Δ8(9),15 
isopimaradiene. Careful analyses revealed that, its 1H and 13C NMR data (Tables 2 and 3) 
were very similar to those of a previously reported compound, kaempulchraol C,7 except for 
the presence of an oxygenated methine group [δH 3.80, t (J = 2.8 Hz), δC 72.9]. The key 
HMBC correlations of H-1β (δH 3.80) to C-5/C-9/C-20, of H-6α [δH 4.57, d (J = 4.8 Hz)] to 
C-8/C-10, and of H-14 [δH 3.56, br s] to C-7/C-9/C-13/C-15/C-17 revealed that these 
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hydroxy groups were located at C-1, C-6, and C-14, respectively. The relative configurations 
at the C-6 and C-14 hydroxy groups were found to be similar to those of kaempulchraol C,7 
while that of the C-1 hydroxy group was found to be in the α orientation, which was 
supported by the NOESY correlations between H-1β and H3-20 as well as by its X-ray 
diffraction pattern as shown in Figure 5. Hence, the structure of 6 was established as 
1α,6β,14α-trihydroxyisopimara-8(9),15-diene, and the compound was named kaempulchraol 
N. 
Table 3 
1H NMR spectroscopic data (600 MHz, CDCl3) for kaempulchraols N (6) and O (7), (δ in ppm and J 
values in (Hz) in parentheses) 
Position 6  7  
1α   
1β 3.80, t (2.8) 3.71, t (2.8) 
2α 1.56, dq, (14.4, 2.8) 1.57, m 
2β 1.92, tq (14.4, 2.2) 1.87, m 
3α 1.65, ddd (17.7, 13.3, 4.0) 1.65, dd (13.5, 4.2) 
3β 1.15, dq (13.3, 2.8) 1.13, dq (14.9, 4.2) 
5α 1.63, br s 1.60, br s 
6α 4.58, d (4.8) 4.55, d (4.5) 
7α 2.76, m 2.35a, m 
7β 2.01, m 2.35a, m 
11α 2.23, m 1.92, m 
11β 2.10, m 2.14, m 
12α 1.82, m 1.48, m 
12β 1.50, m 1.70, m 
14α  3.01, s 
14β 3.56, br s  
15 6.00, dd (17.7, 10.9) 5.75, dd (17.7, 11.0) 
16-a 5.14, dd (17.7, 1.5) 4.90, dd (17.7, 1.2) 
16-b 5.18, dd (10.9, 1.5) 4.99, dd (10.9, 1.2) 
17 1.04, s 1.10, s 
18 1.23, s 1.22, s 
19 1.03, s 1.02, s 
20 1.37, s 1.36, s 
OMe-14  3.53, s 
aOverlapping resonances within the same column. δ values were measured from the HMQC spectrum. 
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Figure 5. Key NOESY correlations (dashed arrows) (a) and ORTEP drawing (b) of compound 6. 
 
Compound 7 was isolated as colorless needles and its molecular formula, C21H34O3, was 
determined from the HREIMS and 13C NMR data. The 1H and 13C NMR spectroscopic data 
(Tables 2 and 3) of 7 were similar to those of 6, except for the presence of a methoxy group 
(δH 3.53, s, δC 62.0) instead of the hydroxyl group of 6. This methoxy group was located at 
C-14, since an oxygenated methine (δH 3.01, s) provided HMBC correlations to 
C-7/C-8/C-9/C-13/C-15/C-17. On the basis of the NOESY correlations (Fig. 6a) between 
H3-20 (δH 1.36, s) and H-1β (δH 3.71, t, J = 2.8)/H-11β (δH 2.14, m), between H-6α (δH 4.55, 
d, J = 4.5) and H-5α (δH 1.60, br s)/H3-19 (δH 1.02, s), and between OMe-14β (δH 3.53, s) 
and H3-17 (δH 1.10, s)/H-12β (δH 1.70, m), the relative configurations of the C-1 and C-6 
hydroxy groups, and the C-14 methoxy groups were assigned as the α, β, and β orientations, 
respectively. The X-ray diffraction analysis data (Fig. 6b) additionally supported the structure 
of 7 as 1α, 6β-dihydroxy-14β-methoxyisopimara-8(9),15-diene, and the compound was 
named kaempulchraol O. 
 
Figure 6. Key NOESY correlations (dashed arrows) (a) and ORTEP drawing (b) of compound 7. 
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The structure of the known compound (1R,2S,5S,9S,10S,11R,13R)-1,2, 
11-trihydroxypimara-8(14),15-diene (8) was identified by comparison of its observed and 
reported NMR data.10 Based on the present study, 1α-hydroxy as well as 6β-hydroxy bearing 
Δ8(9),15 and/or Δ8(14),15 isopimarane diterpenoids are abundant in K. pulchra rhizomes collected 
from Myanmar. 
 
2.2. Antiproliferative activity  
All of the isolated compounds (1−8) were evaluated for their antiproliferative activity 
against five human cancer cell lines (Table 4). The anticancer drug 5-fluorouracil was used as 
a positive control. Compound 1 exhibited mild antiproliferative activity against all of the cell 
lines, with IC50 values ranging from 39.3 to 87.5 µM. Compound 3 was the most active 
compound against A549 cells (IC50 33.1 µM), but it lacked activity against other cell lines. 
Compound 4 had good activity against all of the tested cell lines except for HeLa cells, for 
which it lacked activity. The good antiproliferative activity of compound 4 might be due to  
 
Table 4 
Antiproliferative activity (IC50 µM) of compounds 1−8 isolated from K. pulchra against a panel of 
five human cancer cell lines and normal human primary fibroblast cells 
Cell linea 
Compounds 
A549 HeLa PANC-1 PSN-1 MDA-MB-231 TIG-3 
1 55.8 58.2 70.2 39.9 79.6 87.5 
2 71.6 >100 >100 70.3 >100 >100 
3 33.1 >100 >100 >100 >100 >100 
4 72.3 >100 39.9 22.6 73.6 57.1 
5 45.8 28.4 >100 45.5 >100 >100 
6 >100 >100 >100 >100 >100 >100 
7 >100 >100 >100 >100 >100 >100 
8 93.1 59.4 91.7 99.3 >100 >100 
b5-Fluorouracil 2.8 5.8 3.7 4.4 5.2 8.4 
aA549, human lung cancer; HeLa, human cervix cancer; PANC-1, PSN-1, human pancreatic cancer; 
 MDA-MB-231, human breast cancer; TIG-3, normal human primary fibroblast cell 
bPositive control 
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the presence of the methoxy group at C-9, which is apparently different from the substituents 
of the other isolates. Compounds 6 and 7 had no activity up to 100 µM against all of the 
tested cell lines.  
 
3. Experimental section 
3.1. General experimental procedures 
The melting points were determined with a Yanaco micro melting point apparatus and are 
uncorrected. Optical rotations were recorded on a JASCO P2100 polarimeter. Infrared spectra 
were recorded as KBr pellets on a Jasco FT/IR-460 Plus spectrometer. NMR spectra were 
recorded at 600 MHz (1H NMR) and 150 MHz (13C NMR) on a Varian UNITY 600 
spectrometer. Chemical shift values were expressed in δ (ppm) downfield from TMS as an 
internal standard. The mass spectra, including high-resolution mass spectra, were recorded on 
a JEOL MStation JMS-700 spectrometer. Open column chromatography was performed with 
normal-phase silica gel (silica gel 60N, spherical, neutral, 40−50 µm, Kanto Chemical Co., 
Inc, Tokyo, Japan) and Cosmosil 75C18-OPN (Nacalai Tesque Inc., Kyoto, Japan). MPLC 
was performed with a Büchi Sepacore system (Büchi Labortechnik AG, Flawil, Switzerland). 
TLC was carried out on precoated silica gel 60F254 and RP-18 F254 plates (Merck, 0.25 or 
0.50 mm thickness). The cell lines A549 (human lung cancer), HeLa (human cervix cancer), 
PANC-1 and PSN-1 (human pancreatic cancer), MDA-MB-231 (human breast cancer), and 
TIG-3 (normal human primary fibroblast) were available and maintained in our laboratory. 
Cell culture flasks and 96-well plates were purchased from Corning Inc. (Corning, NY, USA). 
The SH-1200 microplate reader (Corona, Hitachinaka, Japan) was used to measure the 
absorbance of the cells in the antiproliferative activity assay.  
 
3.2. Plant material 
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Kaempferia pulchra Ridl. rhizomes were collected from Pindaya Township, Shan State, 
Myanmar in September 2013, and were identified by an authorized botanist from the 
Department of Botany, University of Yangon. A voucher specimen (TMPW 28301) was 
deposited at the Museum for Materia Medica, Analytical Research Center for 
Ethnomedicines, Institute of Natural Medicine, University of Toyama, Japan.  
 
3.3. Extraction and isolation 
The K. pulchra rhizomes (500 g) were extracted with CHCl3 with sonication (1L, 90 min, 
×3) at 35 °C, and the solvent was evaporated under reduced pressure to yield 30 g of extract.  
The chloroform extract (30 g) was chromatographed on silica gel with an 
EtOAc−n-hexane solvent system to yield seven fractions [1: EtOAc−n-hexane (10:90) eluate, 
0.96 g; 2: EtOAc−n-hexane (15:85) eluate, 1.99 g; 3: EtOAc−n-hexane (20:80) eluate, 6.43 g; 
4: EtOAc−n-hexane (25:75) eluate, 3.52 g; 5: EtOAc−n-hexane (30:70) eluate, 3.84 g; 6: 
EtOAc−n-hexane (40:60) eluate, 1.34 g; 7: EtOAc−n-hexane (50:50) eluate, 3.94 g].  
Fraction 2 (1.99 g) was rechromatographed on Cosmosil 75C18-OPN with 
MeCN−acetone−MeOH−H2O (2:2:2:1) to give three subfractions [2-1: 645 mg; 2-2: 890 mg; 
2-3: 315 mg]. Subfraction 2-2 (890 mg) was subjected to MPLC with n-hexane−EtOAc 
(95:5) [Column: polypropylene (i.d. 40 mm × 150 mm); flow rate: 20 mL/min] to yield 
kaempulchraols I (1, 300 mg), and J (2, 10 mg). Subfraction 2-3 (315 mg) was purified by 
normal phase preparative TLC with C6H6−CH2Cl2−EtOAc (80:80:3) to yield kaempulchraols 
K (3, 10 mg) and L (4, 67 mg). 
Isolation and purification of fractions 3−6 by various chromatographic techniques afforded 
kaempulchraols A−H and five known compounds.7  
The repeated column chromatography of fraction 7 (3.94 g) on Cosmosil 75C18-OPN 
using MeCN−acetone−MeOH−H2O (1:1:1:1) afforded three subfractions [7-1: 350 mg; 7-2: 
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448 mg; 7-3: 2.02 g]. Recrystallization of subfraction 7-1 by acetone furnished 
kaempulchraol M (5, 275 mg). Repeated column chromatography of subfraction 7-3 by 
MPLC [Column: polypropylene (i.d. 40 mm × 150 mm); flow rate: 20 mL/min] with 
n-hexane−CH2Cl2−acetone (4:4:1) and purification by reverse phase preparative TLC with 
MeCN−acetone−MeOH−H2O (1:1:1:2) afforded kaempulchraols N (6, 87 mg) and O (7, 34 
mg), and (1R,2S,5S,9S,10S,11R,13R)-1, 2, 11-trihydroxypimara-8(14),15-diene10 (8, 10 mg).   
 
3.4. Kaempulchraol I (1) 
Amorphous solid;  +81 (c 0.14, MeOH); IR (KBr) νmax 3386, 2948, 2360, 1635, 
1463, 1380, 1211, 1044, 908 cm−1; 1H and 13C NMR data, see Tables 1 and 2; EIMS m/z 288 
[M]+ (8); HREIMS m/z 288.2461 [M]+ (calcd for C20H32O, 288.2453).  
 
3.5. Kaempulchraol J (2) 
Amorphous solid;  +26 (c 0.1, MeOH); IR (KBr) νmax 3453, 2958, 2361, 1681, 
1634, 1597, 1456, 1207, 1047, 919 cm−1; 1H and 13C NMR data, see Tables 1 and 2; EIMS 
m/z 302 [M]+ (14); HREIMS m/z 302.2244 [M]+ (calcd for C20H30O2, 302.4510).  
 
3.6. Kaempulchraol K (3) 
Amorphous solid;  +35 (c 0.1, MeOH); IR (KBr) νmax 3512, 2944, 2362, 1713, 
1363, 1219, 1029, 912 cm−1; 1H and 13C NMR data, see Tables 1 and 2; EIMS m/z 346 [M]+ 
(9); HREIMS m/z 346.2486 [M]+ (calcd for C22H34O3, 346.2508).  
 
3.7. Kaempulchraol L (4) 
Colorless oil;  +40 (c 0.1, MeOH); IR (KBr) νmax 3494, 2917, 1464, 1718, 1636, 
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1464, 1074, 912 cm−1; 1H and 13C NMR data, see Tables 1 and 2; EIMS m/z 318 [M]+ (18); 
HREIMS m/z 318.2561 [M]+ (calcd for C21H34O2, 318.2559).  
 
3.8. Kaempulchraol M (5) 
Colorless needles (acetone); mp 135−140°;  +61 (c 0.13, MeOH); IR (KBr) νmax 
3314, 2953, 2362, 1633, 1366, 1248, 1044, 909 cm−1; 1H and 13C NMR data, see Tables 1 and 
2; FABMS m/z 343 [M + Na]+ (98); HRFABMS m/z 343.2233 [M + Na]+ (calcd for 
C20H32O3Na, 343.2249).  
 
3.9. Kaempulchraol N (6)  
Colorless needles (n-hexane−CHCl3, 7:3); mp 145−148°;  +60 (c 0.12, MeOH); IR 
(KBr) νmax 3361, 2932, 2364, 1638, 1463, 1224, 1067, 1010, 907 cm−1; 1H and 13C NMR data, 
see Tables 2 and 3; EIMS m/z 320 [M]+ (12); HREIMS m/z 320.2342 [M]+ (calcd for 
C20H32O3, 320.2351).  
 
3.10. Kaempulchraol O (7) 
Colorless needles (acetone); mp 100−103°; +145 (c 0.13, MeOH); IR (KBr) νmax 
3402, 2907, 1638, 1459, 1216, 922 cm−1; 1H and 13C NMR data, see Tables 2 and 3; EIMS 
m/z 334 [M]+ (27); HREIMS m/z 334.2514 [M]+ (calcd for C21H34O3, 334.2508).  
 
3.11. X-ray crystallographic analysis of kaempulchraols M−O (5−7) 
X-ray data for compounds 5−7 were collected on a Bruker APEX 2 CCD area detector 
diffractometer with a Helios multi-layered confocal mirror (ϕ−ω scans) using Mo Kα 
radiation (λ = 0.71069 Å) from a Bruker TXS fine-focus rotating anode. Bruker APEX 2 was 
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used for cell refinement and data reduction. The programs SHELXL-97, SHELXL-2014, and 
PLATON were used for the structure solution, the structure refinement, and the ORTEP plot, 
respectively.15−17 Crystallographic data for the structures of compounds 5−7 have been 
deposited in the Cambridge Crystallographic Data Centre (deposition numbers: CCDC 
1060925−1060927). Copies of these data can be obtained, free of charge, upon application to 
the Director, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44-(0)1223-336033 or 
e-mail: deposit@ccdc.cam.ac.uk).  
 
3.12. Crystal data of kaempulchraol M (5) 
C20H32O3, M = 320.46, monoclinic, space group C2, a = 26.401 (15) Å, b = 10.034(5) Å, c 
= 7.896(4) Å, β = 103.475°, V = 2034.3(19) Å3, Z = 4, Dcalcd = 1.046 g/cm3, T = 100 K, 
F(000) = 704, and µ (Mo Kα) = 0.068 mm−1. A total of 5069 reflections (3542 unique, Rint = 
0.0498) were collected from 1.58° to 27.70° in θ and index ranges 34 ≥ h ≥ −23, 13 ≥ k ≥ −11, 
10 ≥ l ≥ −10. The final stage converged to R1 = 0.1205 (wR2 = 0.3455) for 3228 observed 
reflections [with I > 2σ(I)] and 215 variable parameters, and R1 = 0.1261 (wR2 = 0.3526) for 
all unique reflections and GoF = 1.599. 
 
3.13. Crystal data of kaempulchraol N (6) 
C20H32O3, M = 320.46, monoclinic, space group P21, a = 11.1771 (17) Å, b = 23.538 (4) Å, 
c = 18.307 (3) Å, β = 106.809° (2), V = 4610.6 (12) Å3, Z = 2, Dcalcd = 1.165 g/cm3, T = 100 
K, F(000) = 1760, and µ (Mo Kα) = 0.241mm−1. A total of 24589 reflections (17061 unique, 
Rint = 0.0328) were collected from 1.162° to 26.262° in θ and index ranges 12 ≥ h ≥ −13, 29 ≥ 
k ≥ −29, 20 ≥ l ≥ −22. The final stage converged to R1 = 0.0978 (wR2 = 0.2691) for 15633 
observed reflections [with I > 2σ(I)] and 993 variable parameters, and R1 = 0.1036 (wR2 = 
0.2770) for all unique reflections and GoF = 1.047. 
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3.14. Crystal data of kaempulchraol O (7)  
C21H34O3, M = 334.49, triclinic, space group P1, a = 7.6010 (10) Å, b = 15.114 (2) Å, c = 
17.819 (2) Å, α = 103.9984° (17), β = 96.4188° (17), γ = 97.4604° (16), V = 1947.5 (5) Å3, Z 
= 4, Dcalcd = 1.141g/cm3, T = 100 K, F(000) = 736, and µ (Mo Kα) = 0.074 mm−1. A total of 
11980 reflections (10340 unique, Rint = 0.0207) were collected from 1.191° to 29.217° in θ 
and index ranges 10 ≥ h ≥ −9, 20 ≥ k ≥ −18, 24 ≥ l ≥ −13. The final stage converged to R1 = 
0.1309 (wR2 = 0.3660) for 10159 observed reflections [with I > 2σ(I)] and 894 variable 
parameters, and R1 = 0.1319 (wR2 = 0.3705) for all unique reflections and GoF = 1.949. 
 
3.15. In vitro antiproliferative activity 
The in vitro antiproliferative activity of the crude extracts and the isolated compounds 
against the A549 (human lung cancer), HeLa (human cervix cancer), TIG-3 (normal human 
primary fibroblast cell), PANC-1 and PSN-1 (human pancreatic cancer), MDA-MB-231 
(human breast cancer), and TIG-3 (normal human primary fibroblast) cell lines was evaluated 
by the procedure as described previously.7 Briefly, each cell line was seeded in 96-well plates 
(2 × 103 per well) and cultured either in α-MEM or DMEM at 37 °C under a 5% CO2 and 
95% air atmosphere for 24 h. After the cells were washed with PBS (Nissui Pharmaceuticals), 
serial dilutions of the samples to be tested were added. After 72 h incubation, the cells were 
washed with PBS, and 100 µL of α-MEM or DMEM containing 10% WST-8 cell counting 
kit solution (Dojindo; Kumamoto, Japan) was added to the wells. After 2 h incubation, the 
absorbance at 450 nm was measured. The different concentrations of the serial dilutions of 
the tested samples were 100−3.125 µg/mL for the crude extract, 100−3.125 µM for the 
isolated compounds, and 10−0.3125 µM for the positive control, respectively. Cell viability 
was calculated from the mean values of data from three wells by using the following equation, 
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and the antiproliferative activity was expressed as the IC50 (50% inhibitory concentration) 
value. 
 (%) Cell viability = 100 × [{Abs(test samples) − Abs(blank)}/{Abs(control) − Abs(blank)}]  
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The 1H and 13C NMR, 1H−1H COSY, HMQC, HMBC, and NOESY spectra of compounds 
1−7 (Figure S1 − Figure S42). This material is available free of charge via the internet at ----.   
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Figure 1. Structures of compounds 1−8 isolated from K. pulchra rhizomes. 
Figure 2. COSY (bold lines) and key HMBC (1H → 13C) (arrows) correlations in compounds 
1−7. 
Figure 3. Key NOESY correlations (white arrows) in compounds 1 and 4. 
Figure 4. Key NOESY correlations (dashed arrows) (a) and ORTEP drawing (b) of 
compound 5. 
Figure 5. Key NOESY correlations (dashed arrows) (a) and ORTEP drawing (b) of 
compound 6. 
Figure 6. Key NOESY correlations (dashed arrows) (a) and ORTEP drawing (b) of 
compound 7. 
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